Trailhead Biosystems Inc. has completed a $10 million fundraise to accelerate its growth as a maker of specialized human cells used in medical research.
The Beachwood, Ohio-based company has developed a platform that uses "induced pluripotent stem cells" — skin or blood cells that have been reprogrammed back into an embryonic-like state — to make specialized human cells used in therapeutic cell development, drug discovery, organ-on-a-chip development, 3D organ printing and human disease modeling,…
